525 related articles for article (PubMed ID: 29471055)
1. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
Duarte AI; Santos MS; Oliveira CR; Moreira PI
Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
[TBL] [Abstract][Full Text] [Related]
2. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
[TBL] [Abstract][Full Text] [Related]
3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
4. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
Heininger K
Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
[TBL] [Abstract][Full Text] [Related]
5. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
[TBL] [Abstract][Full Text] [Related]
6. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
[TBL] [Abstract][Full Text] [Related]
7. Insulin mediated novel therapies for the treatment of Alzheimer's disease.
Dubey SK; Lakshmi KK; Krishna KV; Agrawal M; Singhvi G; Saha RN; Saraf S; Saraf S; Shukla R; Alexander A
Life Sci; 2020 May; 249():117540. PubMed ID: 32165212
[TBL] [Abstract][Full Text] [Related]
8. Impaired peripheral glucose homeostasis and Alzheimer's disease.
Wijesekara N; Gonçalves RA; De Felice FG; Fraser PE
Neuropharmacology; 2018 Jul; 136(Pt B):172-181. PubMed ID: 29169962
[TBL] [Abstract][Full Text] [Related]
9. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
10. Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis.
Bloom GS; Lazo JS; Norambuena A
Neuropharmacology; 2018 Jul; 136(Pt B):192-195. PubMed ID: 28965829
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice.
Wang P; Su C; Feng H; Chen X; Dong Y; Rao Y; Ren Y; Yang J; Shi J; Tian J; Jiang S
Int J Immunopathol Pharmacol; 2017 Mar; 30(1):25-43. PubMed ID: 28124574
[TBL] [Abstract][Full Text] [Related]
14. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
Kang S; Lee YH; Lee JE
Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
[TBL] [Abstract][Full Text] [Related]
15. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies].
Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D
Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837
[TBL] [Abstract][Full Text] [Related]
16. Insulin and Alzheimer's disease: untangling the web.
Craft S; Cholerton B; Baker LD
J Alzheimers Dis; 2013; 33 Suppl 1():S263-75. PubMed ID: 22936011
[TBL] [Abstract][Full Text] [Related]
17. The role of insulin in the vascular contributions to age-related dementia.
Hughes TM; Craft S
Biochim Biophys Acta; 2016 May; 1862(5):983-91. PubMed ID: 26657615
[TBL] [Abstract][Full Text] [Related]
18. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
Keeney JT; Ibrahimi S; Zhao L
J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
[TBL] [Abstract][Full Text] [Related]
19. Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?
Gratuze M; Joly-Amado A; Vieau D; Buée L; Blum D
Neuroendocrinology; 2018; 107(2):181-195. PubMed ID: 29439247
[TBL] [Abstract][Full Text] [Related]
20. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
